Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-045422

President and CEO sold 18,333 shares at an average $77.25 ($1,416,300)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2021-07-01 Sale −3,030 $76.38 $231,428 2,207,712 I: show line 1 in the form
Watts Ryan J. President and CEO 2021-07-01 Sale −12,844 $77.35 $993,471 2,194,868 I: show line 2 in the form
Watts Ryan J. President and CEO 2021-07-01 Sale −2,459 $77.84 $191,401 2,192,409 I: show line 3 in the form
Open-market sales · 18,333 sh · avg $77.25 · $1,416,300
Loading xslF345X03/doc4.xml…